This trial tests how well carboplatin and paclitaxel work with or without ramucirumab to treat patients with thymic cancer that has spread or returned.
- Unresectable Thymic Carcinoma
- Thymic Carcinoma
- Metastatic Thymic Carcinoma
- Recurrent Thymic Carcinoma
1 Primary · 4 Secondary · Reporting Duration: Up to 2 years
Side Effects for
2 Treatment Groups
Arm B (carboplatin, paclitaxel)
1 of 2
Arm A (ramucirumab, carboplatin, paclitaxel)
1 of 2
66 Total Participants · 2 Treatment Groups
Primary Treatment: Ramucirumab · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 33 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What conditions is Ramucirumab typically prescribed to treat?
"Ramucirumab is the treatment of choice for advanced endometrial cancer, but can also prove effective against melanoma metastasis, lymphoma non-Hodgkin's, and other neoplasms." - Anonymous Online Contributor
What level of risk do patients encounter when taking Ramucirumab?
"The risk associated with Ramucirumab has been estimated at a 2 due to the presence of clinical data that vouch for its safety, though efficacy is yet to be confirmed." - Anonymous Online Contributor
How many individuals have agreed to participate in this trial thus far?
"Affirmative. Information on clinicaltrials.gov demonstrates that this research project, which was published on August 9th 2018, is actively recruiting patients. Approximately 66 subjects must be enrolled from across 100 distinct locations." - Anonymous Online Contributor
Are there still opportunities to volunteer for this research endeavor?
"Affirmative, according to clinicaltrials.gov this study is petitioning for participants which was first advertised on August 9th 2018 and updated lastly on January 6th 2022. The trial demands the recruitment of 66 individuals from 100 distinct sites." - Anonymous Online Contributor
How many healthcare facilities in the state are conducting this clinical experiment?
"Participants of this clinical trial can be recruited from City of Hope South Pasadena in Southern California, Southwest Oncology PC located in Durango, Idaho, and the City of Hope West Covina situated in Alaska. Additionally, there are 100 other locations across the nation." - Anonymous Online Contributor
Have there been any previous inquiries into Ramucirumab's efficacy?
"At the moment, 1202 clinical trials are in progress to investigate Ramucirumab with 336 of those at Phase 3. Shanghai is a major hub for research into this medication; however, there are 68186 medical institutions conducting various experiments across the world." - Anonymous Online Contributor